Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

The Lancet

Volumn 388, Issue 10061, 2016, Pages 2775-2782

  Parikh, Sydel R ^a   Andrews, Nick J ^a   Beebeejaun, Kazim ^a   Campbell, Helen ^a   Ribeiro, Sonia ^a   Ward, Charlotte ^a   White, Joanne M ^a   Borrow, Ray ^a   Ramsay, Mary E ^a   Ladhani, Shamez N ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; 4CMENB VACCINE;

ARTICLE; BACTERIAL STRAIN; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; ENGLAND; FOLLOW UP; HUMAN; INCIDENCE; INFANT; MENINGOCOCCOSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VACCINATION; IMMUNIZATION; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; TREATMENT OUTCOME; UNITED KINGDOM;

HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; PUBLIC HEALTH; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 85003704126     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31921-3     Document Type: Article

References (25)

1. 1 Ladhani, SN, Ramsay, M, Borrow, R, Riordan, A, Watson, JM, Pollard, AJ, Enter B and W: two new meningococcal vaccine programmes launched. Arch Dis Child 101 (2016), 91–95.
2. 2 Campbell, H, Borrow, R, Salisbury, D, Miller, E, Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine 27 (2009), B20–B29.
3. 3 Campbell, H, Saliba, V, Borrow, R, Ramsay, M, Ladhani, SN, Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015. Euro Surveill, 20, 2015, 28.
4. 4 Tan, LK, Carlone, GM, Borrow, R, Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med 362 (2010), 1511–1520.
5. 5 Serruto, D, Bottomley, MJ, Ram, S, Giuliani, MM, Rappuoli, R, The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 30 (2012), B87–B97.
6. 6 Tirani, M, Meregaglia, M, Melegaro, A, Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme. PLoS One, 10, 2015, e0123383.
7. 7 Vernikos, G, Medini, D, Bexsero(R) chronicle. Pathog Glob Health 108 (2014), 305–316.
8. 8 Yamashiro, H, Cutcliffe, N, Dobson, S, Fisman, D, Gold, R, The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective. Can J Infect Dis Med Microbiol 26 (2015), 183–190.
9. 9 Meeting of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/acip/meetings/downloads/agenda-archive/agenda-2015-06.pdf, 2015 (accessed Aug 16, 2016).
10. 10 Joint Committee on Vaccination and Immunisation. JCVI position statement on use of Bexsero meningococcal B vaccine in the UK. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/294245/JCVI_Statement_on_MenB.pdf, 2014 (accessed Aug 8, 2016).
11. 11 Christensen, H, Trotter, CL, Hickman, M, Edmunds, WJ, Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ, 349, 2014, g5725.
12. 12 Piggot, M, Meningitis vaccine for every new UK baby announced by health secretary Jeremy Hunt. International Business Times. http://www.ibtimes.co.uk/meningitis-vaccine-every-new-uk-baby-announced-by-health-secretary-jeremy-hunt-1494025, March 29, 2015 (accessed Aug 8, 2016).
13. 13 Public Health England. Meningococcal Reference Unit-User Manual. Public Health England. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/472708/MRU_User_Manual_FINAL.pdf, 2015 (accessed Aug 15, 2016).
14. 14 Ladhani, SN, Waight, PA, Ribeiro, S, Ramsay, ME, Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources. BMC Infect Dis, 15, 2015, 551.
15. 15 Farrington, CP, Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 22 (1993), 742–746.
16. 16 Public Health England. Provisional vaccine coverage estimates for the new meningococcal B (MenB) immunisation programme for England. Public Health England. https://www.gov.uk/government/publications/meningococcal-b-immunisation-programme-vaccine-coverage-estimates, 2016 (accessed Aug 15, 2016).
17. 17 Donnelly, J, Medini, D, Boccadifuoco, G, et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci USA 107 (2010), 19490–19495.
18. 18 Vogel, U, Taha, MK, Vazquez, JA, et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis 13 (2013), 416–425.
19. 19 Frosi, G, Biolchi, A, Lo Sapio, M, et al. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage. Vaccine 31 (2013), 4968–4974.
20. 20 Basta, NE, Mahmoud, AAF, Wolfson, J, et al. Immunogenicity of a meningococcal B vaccine during a university outbreak. N Engl J Med 375 (2016), 220–228.
21. 21 Brunelli, B, Del Tordello, E, Palumbo, E, et al. Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1. Vaccine 29 (2011), 1072–1081.
22. 22 Cartwright, K, Morris, R, Rumke, H, et al. Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins. Vaccine 17 (1999), 2612–2619.
23. 23 Torres, F, Safadi, M, Martinez, A, et al. Immunogenicity and safety of a 2 or 3 dose primary series of meningococcal serogroup b vaccine in infants, and a 2-dose catch-up series in children. 34th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). Brighton, 2016, ESPID, UK ESP16-0464.
24. 24 Public Health England. Preliminary vaccine coverage estimates for the new meningococcal B (MenB) immunisation programme for England, update to the end of April 2016. Public Health England. https://www.gov.uk/government/publications/meningococcal-b-immunisation-programme-vaccine-coverage-estimates, 2016 (accessed Oct 24, 2016).
25. 25 Public Health England. Provisional vaccine coverage estimates for the new meningococcal B (MenB) immunisation programme for England, January 2016. Public Health England. https://www.gov.uk/government/publications/meningococcal-b-immunisation-programme-vaccine-coverage-estimates, 2016 (accessed Aug 4, 2016).